In a compelling call to action, the Canadian Cancer Society has urged health authorities to lower the recommended age for colorectal cancer screening from 50 to 45. This recommendation stems from alarming trends showing a significant rise in colorectal cancer diagnoses among individuals under 50. As more Canadians face this diagnosis at younger ages, experts argue that proactive measures are essential to improve early detection and survival rates.
A Personal Journey Through Diagnosis
Michael Groves, a 54-year-old resident of Ottawa, experienced the devastating reality of colorectal cancer first-hand. Initially presenting with abdominal pain in January 2021, Groves was relieved when tests ruled out appendicitis. However, a few days later, he noticed blood in his stool, prompting his family doctor to schedule a colonoscopy for April. “The thought of colon cancer never crossed my mind,” Groves shared, reflecting on his active lifestyle and overall good health at the time.
Upon awakening from the procedure, Groves received life-altering news: a five-centimetre tumour had been discovered, and he was diagnosed with Stage 3 colorectal cancer, which had already spread to two lymph nodes. “The shock was just… devastating,” he recalled, highlighting how he had felt perfectly healthy just days before. Following surgery to remove part of his colon and a rigorous six-month chemotherapy regimen, Groves found himself off work for nearly nine months, grappling with the harsh realities of cancer treatment.
Rising Incidence Among Younger Populations
The Canadian Cancer Society’s advocacy for lowering the screening age has gained momentum, especially in light of recent statistics indicating that individuals under 50 are now 2 to 2.5 times more likely to be diagnosed with colorectal cancer than previous generations. Brandon Purcell, the society’s advocacy manager for prevention and early detection, expressed concern over this trend, stating, “It’s time for governments to react to that so that we can catch more of these cancers early.”
Currently, routine screening involves a fecal immunochemical test (FIT) for individuals 50 and older, allowing for at-home stool sample collection. Positive results lead to a follow-up colonoscopy for further investigation. However, many younger individuals, particularly those with risk factors such as family history or gastrointestinal symptoms, are already being referred for proactive screening. Expanding the FIT programme to include those aged 45 and above could significantly enhance early detection.
The Evidence Supports Change
Advocates emphasise that timely screening is crucial, as survival rates can soar to 90% when colorectal cancer is detected early. Conversely, advanced-stage diagnoses carry a dismal survival rate of less than 15%. According to Barry Stein, president and CEO of Colorectal Cancer Canada, colonoscopies not only identify tumours but can also detect and remove precancerous polyps before they progress to cancer— a process that can take several years.
A recent modelling study published in the Journal of the Canadian Association of Gastroenterology supports the push for earlier screening, estimating that starting FIT testing at age 45 could prevent over 15,000 colorectal cancer cases and save approximately 6,100 lives over the next 45 years. The study also suggested substantial cost savings, projecting a $233 million reduction in cancer treatment expenses, even when factoring in the costs associated with increased screening.
Why it Matters
The call to lower the colorectal cancer screening age is not merely a statistic; it is a matter of lives at stake. As more individuals like Michael Groves find themselves facing a cancer diagnosis earlier in life, the healthcare system must adapt to this emerging reality. Implementing routine screenings for those aged 45 and above could drastically improve early detection rates, reduce healthcare costs, and ultimately save lives. The time for action is now—every day counts in the fight against colorectal cancer.
